Sunstar   Report issue

For profit Phase 2 Phase 3
Founded: Etoy Switzerland (1932)
Status: Left NME R&D (2006)

Organization Overview

First Clinical Trial
2006
NCT00529555
First Marketed Drug
2005
chlorhexidine (hibitane)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Sunstar | SUNSTAR AMERICAS | Sunstar, Inc. | Sunstar Italiana SRL.

Active Ingredients

Marketed Drugs (1)

chlorhexidine (hibitane) (2005)

Drugs in Phase 3 Trials (1)

minocycline (minocin) (1 trial)

Drugs in Phase 2 Trials (1)

chlorhexidine (hibitane) (2 trials)

Drugs in Other Trials (1)

lactobacillus reuteri (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 3)

Periodontitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3